ALLMedicine™ Allergic Conjunctivitis Center

May 27th, 2021 - To establish a novel delivery system of pemirolast potassium-loaded gellan gum in situ gel in allergic conjunctivitis therapy. The prepared in situ gels were studied in the following aspects: in vitro gelation, in vitro release, stability, viscosi...

May 24th, 2021 - To evaluate whether allergic conjunctivitis (AC) could be induced by Acanthamoeba excretory-secretory protein (ESP) and analyze the therapeutic effect of resolvin (Rv) D1 and antiallergic agents. Human conjunctival epithelial cells (HCVCs) were tr...

May 15th, 2021 - Studies have implicated temperature and humidity in the pathogenesis of allergic conjunctivitis (AC), as these conditions facilitate air particulate and aeroallergen dispersion and tear film instability. Research also suggests that variation in te...

May 4th, 2021 - To assess the post-acute activity and clinical utility of reproxalap, a novel reactive aldehyde species (RASP) inhibitor, versus vehicle in patients with seasonal allergic conjunctivitis. Parallel-group, double-masked, randomized Phase 3 trial. Tw...

Apr 13th, 2021 - Drugs for allergic rhinitis and allergic conjunctivitis.|2021||administration & dosage,pharmacology,drug therapy,administration & dosage,pharmacology,administration & dosage,pharmacology,methods,administration & dosage,pharmacology,drug therapy,

Nov 12th, 2018 - Evidence-based update using Cochrane Eyes and Vision Group-identified systematic reviews for the initial evaluation of conjunctivitis patients and discussion of associated or predisposing factors.

Mar 13th, 2013 - Ocular allergy represents one of the most common conditions encountered by allergists and ophthalmologists. Allergic conjunctivitis is often underdiagnosed and consequently undertreated. Basic and clinical research has provided a better understand...

May 27th, 2021 - To establish a novel delivery system of pemirolast potassium-loaded gellan gum in situ gel in allergic conjunctivitis therapy. The prepared in situ gels were studied in the following aspects: in vitro gelation, in vitro release, stability, viscosi...

May 24th, 2021 - To evaluate whether allergic conjunctivitis (AC) could be induced by Acanthamoeba excretory-secretory protein (ESP) and analyze the therapeutic effect of resolvin (Rv) D1 and antiallergic agents. Human conjunctival epithelial cells (HCVCs) were tr...

May 15th, 2021 - Studies have implicated temperature and humidity in the pathogenesis of allergic conjunctivitis (AC), as these conditions facilitate air particulate and aeroallergen dispersion and tear film instability. Research also suggests that variation in te...

May 11th, 2021 - Ketorolac tromethamine ophthalmic solution is indicated for the temporary relief of ocular itching due to seasonal allergic conjunctivitis. Ketorolac tromethamine ophthalmic solution is also indicated for the treatment of postoperative inflammatio...

May 4th, 2021 - To assess the post-acute activity and clinical utility of reproxalap, a novel reactive aldehyde species (RASP) inhibitor, versus vehicle in patients with seasonal allergic conjunctivitis. Parallel-group, double-masked, randomized Phase 3 trial. Tw...

Apr 2nd, 2018 - The use of antibiotics in the first 6 months of life was associated with a 14% higher incidence of food allergy but with a 24% higher risk of cow’s milk allergy and egg allergy. Children prescribed antibiotics also had a twofold greater risk of as.

Oct 10th, 2017 - A recent meta-analysis evaluated the risk of intraocular bleeding with newer anticoagulant medications compared with warfarin. A new survey suggests that current therapies to treat allergic conjunctivitis are inadequate. The European Commission re...

Aug 8th, 2017 - Two physicians explore diagnosis and treatment options for the degenerative retinal condition idiopathic macular telangiectasia. How can you plan for retirement when the time is fast approaching? Experts provide advice for soon-to-be-retired physi...

Jun 27th, 2017 - One expert discusses the importance of improving diagnosis and treatment options for nonresponsive bacterial keratitis. A new oral formulation of itraconazole decreased tumor size in patients with basal cell carcinoma nevus syndrome, according to ...

May 30th, 2017 - The FDA has okayed cetirizine ophthalmic solution 0.24% (Zerviate), the first topical ocular formulation of this well-known antihistamine, to treat ocular itching associated with allergic conjunctivitis, the drugmaker, Nicox, announced. The drug's...